| GENFIT S.A. EO -,25 |
| Frankreich |
| Gesundheit |
| FR0004163111 / A0LGJ2 |
| XUP (Frankfurt) |
| FRA:XUP, ETR:XUP, XUP:GR |
| - |
| https://www.genfit.com/ |
|
Genfit S.A. is a BCorp™ certified biopharmaceutical company specializing in the discovery and development of therapeutic solutions for rare and life-threatening liver diseases with high unmet medical needs. As a pioneer in liver disease research wi..
>Volltext.. |
| 444.51 Mio. EUR |
| 494.04 Mio. EUR |
| 67.47 Mio. EUR |
| -8.29 Mio. EUR |
| -88.64 Mio. EUR |
| -1.78 EUR |
| 155.36 Mio. EUR |
| 104.23 Mio. EUR |
| -26.11 Mio. EUR |
| 1.4 |
| -2.34% |
| -5804.58% |
| - |
| - |
| - |
| - |
| GENFIT |
| 29.09.26 |
|